The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
1 Year | 5 Year | 5 Year Annualized | Since IPO | |
---|---|---|---|---|
SOLV | +0.21% | N/A | N/A | -9% |
S&P | +14.5% | +93.32% | +14.09% | +29% |
Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.
Q2 2025 | YOY Change | |
---|---|---|
Revenue | $2.18B | 4.9% |
Gross Profit | $1.39B | 22.4% |
Gross Margin | 63.77% | 9.1% |
Market Cap | $13.12B | 43.7% |
Market Cap / Employee | $0.60M | 0.0% |
Employees | 22K | 0.0% |
Net Income | $90.00M | 1.1% |
EBITDA | $622.00M | 65.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
Q2 2025 | YOY Change | |
---|---|---|
Net Cash | $492.00M | -45.2% |
Accounts Receivable | $1.07B | 3.6% |
Inventory | 962 | 7.0% |
Q2 2025 | YOY Change | |
---|---|---|
Long Term Debt | $7.82B | -5.9% |
Short Term Debt | $0.00M | 0.0% |
Q2 2025 | YOY Change | |
---|---|---|
Return On Assets | 2.56% | 0.0% |
Return On Invested Capital | 9.08% | -2.3% |
Q2 2025 | YOY Change | |
---|---|---|
Free Cash Flow | $59.00M | -80.1% |
Operating Free Cash Flow | $169.00M | -52.4% |
Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
---|---|---|---|---|---|
Price to Earnings | 16.75 | 23.95 | 35.04 | 34.93 | 304.56% |
Price to Book | 4.20 | 3.58 | 4.44 | 4.02 | 69.61% |
Price to Sales | 1.48 | 1.40 | 1.60 | 1.58 | 41.35% |
Price to Tangible Book Value | -1.91 | -1.89 | -2.20 | -3.20 | 90.44% |
Price to Free Cash Flow TTM | 10.34 | 14.32 | 34.52 | 90.39 | 1400.46% |
Enterprise Value to EBITDA | 47.70 | 57.25 | 66.04 | 33.14 | -24.67% |
Free Cash Flow Yield | 9.7% | 7.0% | 2.9% | 1.1% | -93.34% |
Return on Equity | 6.5% | 10.6% | 11.6% | - | |
Total Debt | $8.11B | $8.18B | $7.91B | $7.82B | -5.91% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.